lifestyle.longislandreport.org

Author: Celularity Inc.

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

March 12, 2026
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

March 10, 2026
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

February 12, 2026